Publication | Closed Access

Cytogenetic clonal evolution alone in CML relapse post-transplantation does not adversely affect response to imatinib mesylate treatment

Hematological MalignancyChromatinMesylate TreatmentCell TherapyTransplantationCytogenetic Clonal EvolutionStem Cell TransplantationAffect ResponseCell TransplantationRadiation OncologyMedicineCell BiologyMyeloid Neoplasia